TY - JOUR
T1 - Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus
AU - Schnittman, Samuel R.
AU - Kolossváry, Márton
AU - Beck-Engeser, Gabriele
AU - Fitch, Kathleen V.
AU - Ambayec, Gabrielle C.
AU - Nance, Robin M.
AU - Zanni, Markella V.
AU - Diggs, Marissa
AU - Chan, Fay
AU - McCallum, Sara
AU - Toribio, Mabel
AU - Bamford, Laura
AU - Fichtenbaum, Carl J.
AU - Eron, Joseph J.
AU - Jacobson, Jeffrey M.
AU - Mayer, Kenneth H.
AU - Malvestutto, Carlos
AU - Bloomfield, Gerald S.
AU - Moore, Richard D.
AU - Umbleja, Triin
AU - Saag, Michael S.
AU - Aberg, Judith A.
AU - Currier, Judith S.
AU - Delaney, Joseph A.C.
AU - Martin, Jeffrey N.
AU - Lu, Michael T.
AU - Douglas, Pamela S.
AU - Ribaudo, Heather J.
AU - Crane, Heidi M.
AU - Hunt, Peter W.
AU - Grinspoon, Steven K.
N1 - Publisher Copyright:
© 2023 Oxford University Press. All rights reserved.
PY - 2023/10/1
Y1 - 2023/10/1
N2 - Plasma vascular endothelial growth factor (VEGF) coreceptor neuropilin-1 (NRP-1) had the largest association with coronary plaque in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) proteomics analysis. With little known about NRP-1 in people with human immunodeficiency virus (PWH), we explored its relation to other proteins in REPRIEVE and validated our findings through a Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) case-cohort study by assessing its relation to host factors and incident cardiovascular disease and cancer. Within REPRIEVE, NRP-1 was associated with proteins involved in angiogenesis, signal transduction, immunoregulation, and cell migration/adhesion. Within CNICS, NRP-1 was associated with key host factors, including older age and male sex. NRP-1 was associated with an increased hazard of multiple cancers but a decreased prostate cancer risk. Finally, NRP-1 was most strongly associated with mortality and type 2 myocardial infarction. These data suggest that NRP-1 is part of a clinically relevant immunoregulatory pathway related to multiple comorbidities in PWH. Clinical Trials Registration. NCT02344290.
AB - Plasma vascular endothelial growth factor (VEGF) coreceptor neuropilin-1 (NRP-1) had the largest association with coronary plaque in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) proteomics analysis. With little known about NRP-1 in people with human immunodeficiency virus (PWH), we explored its relation to other proteins in REPRIEVE and validated our findings through a Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) case-cohort study by assessing its relation to host factors and incident cardiovascular disease and cancer. Within REPRIEVE, NRP-1 was associated with proteins involved in angiogenesis, signal transduction, immunoregulation, and cell migration/adhesion. Within CNICS, NRP-1 was associated with key host factors, including older age and male sex. NRP-1 was associated with an increased hazard of multiple cancers but a decreased prostate cancer risk. Finally, NRP-1 was most strongly associated with mortality and type 2 myocardial infarction. These data suggest that NRP-1 is part of a clinically relevant immunoregulatory pathway related to multiple comorbidities in PWH. Clinical Trials Registration. NCT02344290.
KW - HIV
KW - VEGF
KW - cancer
KW - cardiovascular disease
KW - neuropilin-1
UR - http://www.scopus.com/inward/record.url?scp=85176439222&partnerID=8YFLogxK
U2 - 10.1093/ofid/ofad467
DO - 10.1093/ofid/ofad467
M3 - Article
AN - SCOPUS:85176439222
SN - 2328-8957
VL - 10
JO - Open Forum Infectious Diseases
JF - Open Forum Infectious Diseases
IS - 10
ER -